Incidence density (number/year/100) | RR (95% CI) | p | |||||
---|---|---|---|---|---|---|---|
Biopsy confirmed (n=207) | Negative biopsy (n=85) | ||||||
Relapses | 38.2 | 36.93 | 1.01 (0.95, 1.08) | 0.72 | |||
Blindness | 2.97 | 0 | 1.01 (1.01, 1.02) | 0.09 | |||
Visual problems | 10.70 | 13.88 | 0.98 (0.95, 1.02) | 0.31 | |||
Myocardial infarction | 0.84 | 1.68 | 0.99 (0.97, 1.01) | 0.43 | |||
Stroke | 1.74 | 6.74 | 0.97 (0.95, 01.00 | 0.008 | |||
Transient ischaemic episode | 2.23 | 3.41 | 0.99 (0.98, 1.01) | 0.50 | |||
Lower limb arteritis | 1.54 | 0.34 | 1.01 (0.99, 1.02) | 0.76 | |||
Hypertension | 12.47 | 14.41 | 0.98 (0.95, 1.02) | 0.39 | |||
Diabetes | 8.00 | 17.66 | 0.95 (0.92, 0.99) | 0.005 |
Occurring events have been recorded at each six month assessment. Incidence densities have been computed for each six month period of follow up, and compared with a Mantel-Haenzsel test. A Mantel-Haenzsel weighted relative risk (RR) has been computed across the six month strata, with a Greenland-Robins test with 95% confidence intervals.